
Loading, please wait...

Loading, please wait...

Modern drug discovery is shifting from the "one drug, one target" model to a more complex understanding of multi-target interactions. Specifically, the PPB3 target prediction tool has emerged as a powerful web-based solution for assessing polypharmacology. By identifying how drug-like molecules interact with multiple biological targets, researchers can better predict both therapeutic potential and unintended side effects.
Furthermore, the PPB3 model utilizes deep neural networks trained on the extensive ChEMBL 34 database. This dataset includes over 1.1 million molecules and roughly 2.5 million interactions. Consequently, the tool covers 7,546 targets, including cell lines and organisms, which were often excluded from previous versions. Therefore, this expanded scope provides a much more comprehensive view of molecular bioactivity than older protein-only models.
Specifically, the tool excels in precision and recall when identifying targets where a molecule is significantly active. Additionally, users can perform these predictions online, making high-level bioinformatics accessible to a broader scientific community. Moreover, understanding these interactions is crucial for drug repurposing efforts in India and globally. Consequently, this technology helps clinicians and researchers identify new uses for existing drugs while minimizing toxicity risks. However, users should always validate computational predictions with experimental data.
The PPB3 tool uses deep learning to predict the biological targets of small molecules, helping researchers understand polypharmacology profiles and potential side effects.
The current version uses ChEMBL 34, containing a much larger dataset of over 7,500 targets, including cell lines and protein complexes, compared to older models limited to single proteins.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or as a substitute for professional healthcare. Always seek the advice of a qualified health provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed PPB3, a deep learning tool for target prediction and polypharmacology assessment, utilizing a vast dataset of 7,546 targets....
5 months ago

Hospitalized older adults face significant risks of functional decline due to prolonged bed rest. This qualitative study explores how introducing dedicated mobility technicians supports inpatient ambulation, alleviates nursing workloads, and improves patient outcomes through strong interprofessional collaboration.
Today

A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Today

A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Yesterday

A systematic review and Bayesian network meta-analysis evaluates the efficacy of intravenous and oral acetaminophen regimens for pain management and supplemental analgesic consumption following total joint arthroplasty.
Today

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
Today